These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26137410)

  • 21. Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.
    Vuk-Pavlović S; Bulur PA; Lin Y; Qin R; Szumlanski CL; Zhao X; Dietz AB
    Prostate; 2010 Mar; 70(4):443-55. PubMed ID: 19902470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD14++ CD16+ HLA-DR+ Monocytes in Peripheral Blood are Quantitatively Correlated with the Severity of Pre-eclampsia.
    Tang MX; Zhang YH; Hu L; Kwak-Kim J; Liao AH
    Am J Reprod Immunol; 2015 Aug; 74(2):116-22. PubMed ID: 25850575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune monitoring using the predictive power of immune profiles.
    Gustafson MP; Lin Y; LaPlant B; Liwski CJ; Maas ML; League SC; Bauer PR; Abraham RS; Tollefson MK; Kwon ED; Gastineau DA; Dietz AB
    J Immunother Cancer; 2013; 1():7. PubMed ID: 25512872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating CD14(+)HLA-DR(-/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC.
    Huang H; Zhang G; Li G; Ma H; Zhang X
    Tumour Biol; 2015 Sep; 36(10):7987-96. PubMed ID: 25967454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass.
    Quimby KR; Greenidge A; Harris A; Landis RC
    Cytometry B Clin Cytom; 2010 Sep; 78(5):357-60. PubMed ID: 20533393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Early-Stage Human Breast Carcinoma on Monocyte Programming.
    Patysheva M; Larionova I; Stakheyeva M; Grigoryeva E; Iamshchikov P; Tarabanovskaya N; Weiss C; Kardashova J; Frolova A; Rakina M; Prostakishina E; Zhuikova L; Cherdyntseva N; Kzhyshkowska J
    Front Oncol; 2021; 11():800235. PubMed ID: 35237501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR expression and differential trafficking of monocyte subsets following low to intermediate risk surgery.
    Handy JM; Scott AJ; Cross AM; Sinha P; O'Dea KP; Takata M
    Anaesthesia; 2010 Jan; 65(1):27-35. PubMed ID: 19889110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanded CD14
    Zhang R; Shi J; Zhang R; Ni J; Habtezion A; Wang X; Hu G; Xue J
    J Immunol; 2019 May; 202(9):2578-2584. PubMed ID: 30894427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.
    Ruppert J; Friedrichs D; Xu H; Peters JH
    Immunobiology; 1991 Aug; 182(5):449-64. PubMed ID: 1717365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
    Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
    Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on monocyte HLA-DR expression in critically ill patients after surgery].
    Zhang YT; Fang Q
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1480-2. PubMed ID: 17349175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD163 and HLA-DR molecules on the monocytes in chronic lymphocytic leukemia patients.
    Kowalska W
    Folia Histochem Cytobiol; 2020; 58(1):17-24. PubMed ID: 32176313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the proportion of non-classic (CD14+CD16+) monocytes/macrophages in peripheral blood and gingiva of healthy individuals and patients with chronic periodontitis.
    Jagannathan R; Lavu V; Rao SR
    J Periodontol; 2014 Jun; 85(6):852-8. PubMed ID: 24001047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
    Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
    Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
    Yuan XK; Zhao XK; Xia YC; Zhu X; Xiao P
    J Int Med Res; 2011; 39(4):1381-91. PubMed ID: 21986138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma.
    Dayyani F; Joeinig A; Ziegler-Heitbrock L; Schmidmaier R; Straka C; Emmerich B; Meinhardt G
    J Leukoc Biol; 2004 Feb; 75(2):207-13. PubMed ID: 14576364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.